Genetics, Vol. 152, 129-141, May 1999, Copyright © 1999

A Mutation in GRS1, a Glycyl-tRNA Synthetase, Affects 3'-End Formation in Saccharomyces cerevisiae

Christi Magrath1,a and Linda E. Hymanb
a Interdisciplinary Program in Molecular and Cellular Biology, Tulane University, New Orleans, Louisiana 70112
b Department of Biochemistry, Tulane University Medical School, New Orleans, Louisiana 70112

Corresponding author: Linda E. Hyman, Department of Biochemistry, Tulane University Medical School, New Orleans, LA 70112., lhyman{at}mailhost.tcs.tulane.edu (E-mail)

Communicating editor: F. WINSTON


*  ABSTRACT
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

3'-end formation is a complex and incompletely understood process involving both cis-acting and trans-acting factors. As part of an effort to examine the mechanisms of transcription termination by RNA polymerase II, a mutant hunt for strains defective in 3'-end formation was conducted. Following random mutagenesis, a temperature-sensitive strain exhibiting several phenotypes consistent with a role in transcription termination was isolated. First, readthrough of a terminator increases significantly in the mutant strain. Accordingly, RNA analysis indicates a decrease in the level of terminated transcripts, both in vivo and in vitro. Moreover, a plasmid stability assay in which high levels of readthrough lead to high levels of plasmid loss and transcription run-on analysis also demonstrate defective termination of transcription. Examination of polyadenylation and cleavage by the mutant strain indicates these processes are not affected. These results represent the first example of a transcription termination factor in Saccharomyces cerevisiae that affects transcription termination independent of 3'-end processing of mRNA. Complementation studies identified GRS1, an aminoacyl-tRNA synthetase, as the complementing gene. Sequence analysis of grs1-1 in the mutant strain revealed that nucleotides 1656 and 1657 were both C to T transitions, resulting in a single amino acid change of proline to phenylalanine. Further studies revealed GRS1 is essential, and the grs1-1 allele confers the temperature-sensitive growth defect associated with the mutant strain. Finally, we observed structures with some similarity to tRNA molecules within the 3'-end of various yeast genes. On the basis of our results, we suggest Grs1p is a transcription termination factor that may interact with the 3'-end of pre-mRNA to promote 3'-end formation.


TRANSCRIPTION termination requires the dissociation of the tertiary complex formed by the DNA template, the transcribing RNA polymerase, and the nascent RNA. Accurate termination is required for wild-type levels of gene expression as readthrough transcription into an adjacent gene results in reduced expression of the downstream transcriptional unit (PROUDFOOT 1986 Down; EGGERMONT and PROUDFOOT 1993 Down; SPRINGER et al. 1997 Down; GREGER et al. 1998 Down) and may also result in decreased expression of the affected gene (ZARET and SHERMAN 1982 Down; WHITELAW and PROUDFOOT 1986 Down).

The investigation of transcription termination by RNA polymerase II is complicated by the 3'-end processing of the pre-mRNA, which is coupled to the termination of transcription (HYMAN and MOORE 1993 Down; RUSSO 1995 Down; MCCRACKEN et al. 1997 Down; BIRSE et al. 1998 Down). Once the RNA polymerase II transcribes past the polyadenylation site, three significant and interrelated reactions occur: pre-mRNA cleavage, polyadenylation, and termination. The cleavage reaction results in the production of two RNAs; these are the upstream cleavage product, containing the functional mRNA, and the downstream cleavage product that has no coding capacity and is rapidly degraded in vivo. The upstream product is further processed by the addition of a tract of adenylate residues that comprises the poly(A) tail (reviewed in COLGAN and MANLEY 1997 Down; PREKER et al. 1997 Down). The downstream product is subject to termination of transcription, an event that defines the end of transcription.

Numerous trans-acting factors have been identified in yeast as having roles in 3'-end formation, including the ~20 gene products that have direct roles in the biochemical processing of pre-mRNAs in vitro (WAHLE and KELLER 1996 Down; reviewed in KELLER and MINVIELLE-SEBASTIA 1997 Down). Some of these factors, including Rna14p, Rna15p, and Pcf11p, are known to be important for both RNA processing and transcription termination, thus providing a mechanistic bridge between the key events involved in 3'-end formation (BIRSE et al. 1998 Down). Other genes have also been identified by the genetic characterization of mutations that affect 3'-end formation. For example, REF2 was discovered using a screen for mutations that lead to inefficient recognition of wild-type polyadenylation signals (RUSSNAK et al. 1995 Down). Recently, Ptf1, the gene for the protein processing protein cis-/trans-prolyl isomerase was identified in a genetic screen for factors involved in transcription termination by RNA polymerase II in Saccharomyces cerevisiae (HANI et al. 1999 Down). An additional set of mutations affecting 3'-end formation was isolated as a suppressor of the pap1-1 mutation, including a mutation in the second-largest subunit of RNA polymerase III (BRIGGS and BUTLER 1996 Down) and a mutation in RRP6, a gene involved in 5.8S rRNA biosynthesis (BRIGGS et al. 1998 Down), suggesting unexpected overlap of function of proteins not expected to play a role in RNA polymerase II 3'-end formation. Finally, mammalian 3'-end formation proteins involved in cleavage and polyadenylation interact with the C-terminal domain of the largest subunit of RNA polymerase II, providing a mechanism, in principle, for linking transcription and RNA processing in vivo (MCCRACKEN et al. 1997 Down; STEINMETZ 1997 Down). Thus, although many of the factors involved in 3'-end processing and transcription termination are being defined, an understanding of how these factors are integrated with each other and the actual events that lead to 3'-end formation in vivo is still unclear. Here we report the novel finding that a mutation in GRS1, the probable gene for glycyl-tRNA synthetase, also affects 3'-end formation in S. cerevisiae.


*  MATERIALS AND METHODS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Reagents:
Culture media components were obtained from Difco (Detroit). Amino acids, 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal) and o-nitrophenyl-ß-D-galactosidase (ONPG), as well as most other chemicals, were from Sigma (St. Louis). T4 DNA ligase was obtained from New England Biolabs (Beverly, MA). Most restriction enzymes, T3, SP6, and T7 polymerases, RNasin, calf intestine alkaline phosphatase, and Taq DNA polymerase were obtained from Promega (Madison, WI). All reagents were used according to manufacturer's specifications. Radiolabeled nucleotides were obtained from Dupont/NEN (Boston). Sequenase enzyme was obtained from Amersham (Arlington Heights, IL). Nylon transfer membrane was from Micron Separations (Westborough, MA).

Plasmids:
The plasmids, pL101 and pT7T3ADH2 (HYMAN et al. 1991 Down), pL501 (HYMAN and MOORE 1993 Down), pT7T3URA3 (CHEN et al. 1996 Down), YCplac111 and YCplac211 (GIETZ et al. 1992 Down), pBEVY (MILLER et al. 1998 Down), pCYC (BUTLER and PLATT 1988 Down), pGCYC and pGcyc-512 (BIRSE et al. 1998 Down), and pBM272 (JOHNSTON and DAVIS 1984 Down; ROSE et al. 1987 Down) have been previously described. YCpMM3 is identical to YRp14/CEN4/H4ARS (HIETER et al. 1985 Down). p366 (ATCC 77163) and the yeast genomic library (ATCC 77162) were obtained from ATCC.

pGTP and pGTM were constructed by amplifying an ADH2 3'-end fragment by PCR of pT7T3ADH2 with primers (5'GAAGATCTGACACTTCTAAATAAGCGG and 5'GAAGATCTGGCATGCGAAGGAAAATGAG) that created BglII sites (in boldface) on both ends of the PCR fragment. Following digestion with BglII, the fragment was cloned into the BamHI site of pBM272, creating pBM272 derivatives with the ADH2 3'-end downstream of the GAL1 promoter in both orientations (plus and minus relative to the GAL1 promoter). These GAL1/ADH2 3'-end fusions (+ and -) were used as templates for PCR with primers (5'GAAGATCTTCGCCCCATTATCTTAGCC and 5'GCCAGCAACCGCACC), which created a BglII site (in boldface) on the 5'-end of the PCR fragment. Following digestion of the PCR product with BglII and HindIII and the vector, YCpMM3, with BamHI and HindIII, the fragments were ligated to generate pGTP and pGTM. pGTP contains the plus orientation of ADH2 and pGTM contains the minus orientation.

YCplac111/TFC1 was obtained by digesting the genomic library clone, p366/711, with NsiI and ligating the 3212-bp gel-purified restriction fragment into the PstI site of YCplac111. Digesting YCp111/TFC1 with XmnI and SmaI and ligating the resulting fragment into the SmaI site of YCp111 generated YCp111/YBR124W. YCp111/MRPL36 was constructed by digesting p366/57 with EcoRV and ligating the 1479-bp product into the SmaI site of YCp111. p366/57{Delta}tfc1 was generated by digesting the genomic library clone, p366/57, with SacI and religating the plasmid to delete the region of TFC1 between the two SacI sites. p366/76{Delta}GRS1 was generated by digestion of the genomic library clone, p366/76, with MscI and religating the plasmid to delete the region of GRS1 between the two MscI sites that flank GRS1. A third MscI site, located within the vector p366, is blocked by dam methylation. To construct YCp111/grs1-1, the GRS1 gene was cloned from genomic DNA preparations of both the wild-type (YPH499) and mutant (2-1-1) strains after introducing flanking BamHI and XbaI restriction sites (in boldface) by PCR, using the primers LEH285 (5' CGGGATCCAGTGTAGAAGATATC) and LEH286 (5' GCTCTAGAGATTTCCGCACTTC). For each independent PCR reaction (four or more reactions from both strains), the PCR fragments and vectors were digested with BamHI and XbaI and cloned into the XbaI and BamHI site of the centromeric vectors YCplac111 and pT7T319U. The PCR-derived GRS1-containing plasmids were transformed into 2-1-1 and temperature sensitivity at 37° was assessed. Strains that contained plasmid derivatives that did not complement the temperature sensitivity were identified, and plasmid YCp111/grs1-1 isolated from the strains. The grs1-1 allele was excised from YCp111/grs1-1 as a PstI/EcoRI fragment and cloned into PstI/EcoRI cut YIplac211, creating YIp211/grs1-1. As a control, an identical protocol was used to remove a wild-type version of GRS1 from the genome of W303a creating the plasmids YCp111/GRS1 and YIp211/GRS1. All plasmids used in the genetic study are shown in Table 1.


 
View this table:
In this window
In a new window

 
Table 1. Plasmids used in genetic study

UV mutagenesis and screening strategy:
YPH499 was transformed with the reporter plasmid, pL101, using the lithium acetate method (AUSUBEL et al. 1994 Down). In excess of 45,000 YPH499 cells with pL101 were plated to complete minimal dextrose media plates without uracil, at ~1000 cells per plate. The plates were then immediately subjected to UV light at a dosage of 675 J/m2, resulting in 65–80% cell death, and incubated at 24° for 3–5 days, until colonies were fully formed. The colonies were replica plated to complete minimal galactose media without uracil and with X-Gal (CUXG; AUSUBEL et al. 1994 Down) and incubated at 37°, 24°, and 16°. Colonies that produced ß-galactosidase were patched to complete minimal glucose media plates without uracil and grown at 24°. The strains were screened on X-Gal plates at 37°, 24°, and 16°. Strains that consistently produced ß-galactosidase on the CUXG indicator plates at any of the three temperatures were chosen for further study.

Elimination of plasmid-based mutations:
Candidate strains were cured and retransformed with the pL101 plasmid using a scaled down lithium acetate protocol (FIRMENICH and REDDING 1993 Down; AUSUBEL et al. 1994 Down). The retransformed strains were then screened on X-Gal plates for ß-galactosidase production at 37°, 24°, and 16°. Temperature-sensitive growth at any of these temperatures was monitored.

Northern analysis:
Cells were grown to saturation in complete minimal dextrose media without uracil and the saturated cultures were used to inoculate complete minimal galactose media without uracil. These induced cells were grown to saturation (OD600 of 1.5–2.0), reinoculated, and harvested when the OD600 was 0.5–1.0. For temperature-shift studies, cells were grown to an OD600 between 0.15 and 0.5, split, and grown at the appropriate temperatures for 7–24 hr. Total RNA was prepared using the hot phenol/glass beads method. Samples were electrophoresed on 1.5%-agarose/formaldehyde gel, and Northern analysis performed. [{alpha}-32P]UTP-labeled ADH2 and URA3 probes were made and hybridization was completed. All procedures for RNA analysis were as previously described (HYMAN et al. 1991 Down; HYMAN and MOORE 1993 Down; AUSUBEL et al. 1994 Down).

Plasmid loss analysis:
Strains transformed with either plasmid pGTP or pGTM were grown in complete minimal dextrose media without uracil and inoculated into YPD or YPGal (AUSUBEL et al. 1994 Down). At various time points, approximately every 2–4 hr, cells were counted using a hemacytometer and ~500 cells were plated to YPD. The total number of colonies and the number of red or non-red colonies (white or sectored) were determined. Percent plasmid maintenance was calculated as percent non-red/total colonies. For temperature-shift experiments, the YPD or YPGal cultures were grown to early log phase (OD600 of 0.2) and split to the permissive and nonpermissive temperatures.

Random spore analysis:
Strain 2-1-1 transformed with pL101 was mated to YPH500 transformed with YCplac211, and diploids (2-1-1/500) were selected on complete minimal dextrose plates without uracil or leucine. Sporulation was induced by growth on plates supplemented with histidine, adenine, lysine, and tryptophan (AUSUBEL et al. 1994 Down). One of the spore progeny (2-1-1-B) was grown in nonselective media to induce plasmid loss. The strain was retransformed with pL101 and backcrossed to YPH500; diploids (2-1-1-B/500) were selected, as above. Following sporulation, random spore analysis was performed as described in AUSUBEL et al. 1994 Down. Plates containing dispersed spores were replica plated to X-Gal plates and screened at 30° and 37° for growth and ß-galactosidase production.

Yeast extracts and in vitro transcription:
Yeast nuclear extracts were prepared from 2-1-1 and BJ926 by the methods of GUTHRIE and FINK 1991 Down, LUE et al. 1991 Down, and LUE and KORNBERG 1987 Down, except the final OD600 of 2-1-1, which was 2.9. Briefly, dense cell cultures were prepared and harvested. Spheroplasts were prepared from the cultures using digestion with yeast lytic enzyme, and, following a period of recovery by growth in rich media, the cells were washed extensively. The cells were then homogenized using conditions that preserved the intact nuclei. The nuclei were recovered by centrifugation and the nuclear proteins were prepared. Protein concentration was determined by Bradford Assay (Bio-Rad, Hercules, CA). Transcription reactions were carried out as previously described (LUE and KORNBERG 1987 Down; LUE et al. 1991 Down). The transcripts were analyzed on a 1.5%-agarose/formaldehyde gel.

Polyadenylation and cleavage extracts:
Yeast whole-cell extracts were prepared according to published procedures (BUTLER and PLATT 1988 Down; CHEN and MOORE 1992 Down). The full-length CYC1 precursor was made by in vitro transcription using SP6 polymerase and the pCYC template digested with PvuII. Radiolabeled RNA substrate was gel purified from a 5% polyacrylamide gel with 8.3 M urea. Approximately 70,000 cpm were added to the extracts. Processing reactions were performed at 30° for 30 min. Heat-treated extracts were incubated at 37° for 5 min prior to addition of RNA substrate. dATP was substituted for ATP for the cleavage-only reactions. Results were visualized on a 5% denaturing acrylamide gel.

Transcription run-on:
Examination of transcription run-on was completed as described in BIRSE et al. 1998 Down with the following modifications: YCM101 and W303a were used and the temperature shift was for 2 hr at 37°. Briefly, cells (containing the plasmid pGCYC or pGcyc-512) grown on complete minimal galactose plates without tryptophan were used to inoculate liquid media that was incubated at 30°. The cultures were grown to early log phase (OD600 was 0.05–0.1) and harvested. For temperature-shift experiments, the cells were resuspended in media and grown at 37° for ~2 hr. The samples were washed in cold water and treated with Sarkosyl. The resulting cell pellets were used in a transcription reaction. Total RNA was isolated from the cells and hybridized overnight (24°) to a slot blot containing M13 probes specific for regions of CYC1 gene. After being washed, the filters were analyzed by autoradiography.

Complementation:
Strain 2-1-1 was transformed with 0.5 µg of yeast genomic library ATCC 77162, plated to complete minimal dextrose plates without uracil, and incubated at 37°. Eight independent transformations were completed and at least 20 genome equivalents of library DNA were screened. The transformants that appeared at the restrictive temperature were selected and the recovery of growth at 37° was confirmed. Plasmids were recovered from strains with restored growth and amplified in Escherichia coli (DH5{alpha}; AUSUBEL et al. 1994 Down). Restriction analysis was used to determine the number of independent genomic library inserts. DNA was sequenced by the double-stranded dideoxy sequencing technique with Sequenase using primers that flanked the BamHI genomic library fragment insertion site of p366 (5'GCCGGCCACGATGCG and 5'GGCGACCACACCCG). The sequence was then used in a BLAST search (ALTSCHUL et al. 1990 Down; CHERRY et al. 1997 Down, Saccharomyces Genome Database) and the ends of the genomic inserts were defined.

Generation and analysis of GRS1 null strain:
Generation of a grs1{Delta}/GRS1 derivative of W303a/{alpha} was completed using the kan/lox method (GULDENER et al. 1996 Down), with primers specific for the region ~100 bp upstream and downstream of the GRS1 locus (LEH290, 5'CGTATTAGTGGACAGTACATAATCATATCTTGCAATACGTATCAGCTGAAGCTTCGTACGC and LEH289, CAGTAGACGATTTTACTCTCAGATTGTTAAAAAATCGGTTAAGCATAGGCCACTAGTGGATCTG). The genotype of G418 resistant colonies was determined using PCR with primers specific for the kanamycin cassette (GULDENER et al. 1996 Down), paired with LEH289 or LEH290. The resulting heterozygotic strain (YCM103) was sporulated and dissected. The spore products were analyzed on YPD and YPD plus G418 media at 30° and 37° to determine if a haploid grs1 null strain was viable.

Generation of integrant:
YIP211/grs1-1 and YIP211/GRS1 were transformed into yeast, and potential integrants were selected on the basis of the ability to grow on complete minimal dextrose media without uracil (AUSUBEL et al. 1994 Down). Integration of the plasmid sequence harboring the URA3 gene and the grs1-1 allele from the 2-1-1 background (resulting in strain YCM102) was confirmed by Southern analysis (not shown). After growth on 5-fluoroorotic acid, strains that had recombined between the two tandemly arrayed GRS1 alleles (grs1-1 and GRS1) were selected (GUTHRIE and FINK 1991 Down; AUSUBEL et al. 1994 Down). Multiple strains containing a single copy of the mutant grs1 allele (renamed as YCM101) were selected on the basis of temperature sensitivity at 37°. To confirm our previous genetic linkage data, YCM101 transformed with pL101 was mated to W303{alpha} transformed with p366, and diploids were selected on complete minimal dextrose plates without uracil or leucine. The resulting diploids were dissected and the phenotypes of the resulting segregants were examined on YPD, complete minimal dextrose plates without uracil and X-gal indicator plates at the permissive (30°) and nonpermissive (37°) temperatures.

DNA sequencing:
The T7T319U derivatives constructed from the mutant background (above) were used for DNA sequencing. Independently derived clones were sequenced and compared to clones derived from the wild-type strain. DNA was sequenced by the double-stranded dideoxy sequencing technique with Sequenase (USB/Amersham).

Yeast strains and methods:
All mutant strains are derivatives of the S. cerevisiae strain YPH499 or W303 (Table 2). Yeast cells were cultured by standard techniques (SHERMAN et al. 1986 Down; GUTHRIE and FINK 1991 Down; AUSUBEL et al. 1994 Down).


 
View this table:
In this window
In a new window

 
Table 2. Yeast strains used in this study


*  RESULTS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Mutagenesis of YPH499 to create defects in trans-acting factors involved in transcription termination:
As part of an effort to examine the mechanisms of transcription termination by RNA polymerase II, a mutant hunt for strains defective in 3'-end formation was conducted. The reporter plasmid pL101 was used as the primary indicator of increased readthrough transcription (Figure 1A). pL101 contains a galactose inducible promoter that drives transcription into an intron-imbedded transcription termination signal placed upstream of the lacZ gene. Consequently, ß-galactosidase production serves as an indication of the efficiency of transcription termination (HYMAN et al. 1991 Down). In wild-type cells termination occurs within the intron because of recognition of the ADH2 3'-end formation signal, and the cells do not produce ß-galactosidase, thus producing white colonies on indicator plates. However, when readthrough of the termination signal occurs, the LacZ gene downstream from the intron is transcribed and, following removal of the termination signal by splicing, the cells produce ß-galactosidase, thus producing blue colonies on indicator plates.




View larger version (35K):
In this window
In a new window
Download PPT slide
 
Figure 1. Reporter construct used in analysis of trans-acting factors. (A) LacZ reporter construct. When the plasmid pL101 is transformed into mutant or wild-type cells, varying levels of readthrough can be detected by both a color assay, based on ß-galactosidase production from the LacZ gene, and Northern analysis, based on hybridization of an antisense ADH2 3'-end specific probe. (B) Northern analysis of mutant strains. Cells containing the pL101 reporter plasmid were grown in complete minimal galactose media minus uracil and leucine at the temperature indicated. Total RNA (5 µg) was run on a 1.5%-agarose/formaldehyde gel. Following transfer, transcripts were detected using a radiolabeled antisense ADH2 3'-end specific probe with URA3 as a loading control. Total RNA from a nonmutant strain (3-2-2) is shown for comparative purposes.

Using this reporter in an analysis of ~46,000 UV-mutagenized S. cerevisiae cells, we sought to identify mutations that give poor 3'-end formation at a permissive temperature (24°) but are nonviable at a nonpermissive temperature (16° or 37°). Approximately 300 ß-galactosidase-producing strains were identified and analyzed.

Additional screening of potential mutants to eliminate false positives:
To eliminate false positives that were expected to arise because of plasmid-borne mutations (i.e., cis-mutations of the ADH2 3'-end signal), each putative mutant strain was cured of the original plasmid, retransformed with pL101, and retested for ß-galactosidase production. Subsequently, to reduce the pool of the 120 remaining strains, only those candidates that exhibited a temperature-sensitive phenotype in addition to increased ß-galactosidase production were selected for continued investigation, leaving 20 strains for RNA analysis.

Northern analysis:
Total RNA was prepared from these 20 candidates containing pL101 and examined by Northern blotting using the ADH2 3'-end sequence as a probe. The amount of hybridization to this probe correlates to the level of correctly terminated transcripts produced by the reporter plasmid. Readthrough transcripts do not contain the ADH2 3'-end sequence, as this sequence is located within a functional intron. Consequently, the readthrough transcripts are not detected by the ADH2 3'-end specific probe (HYMAN et al. 1991 Down). Of the 20 remaining strains, we observed different classes of mutations; some strains had no obvious defect in RNA synthesis (1-20-4, 3-2-2), while others had subtle (4-12-3, 3-4-5) or severe defects (2-1-1, 3-17-3; Figure 1B).

Analysis of mutants by plasmid loss assay:
To increase the rigor of the screen and eliminate mutations that are due to indirect effects, a second complementary reporter system based on a plasmid instability assay (SNYDER et al. 1988 Down) was used. Mutant phenotypes that may result from indirect effects on RNA metabolism, including splicing, transport, stability, and translational efficiency, are eliminated by the plasmid loss analysis using pGTP and pGTM (described below and in Figure 2A; KOSHLAND et al. 1985 Down; SNYDER et al. 1988 Down). As this assay does not rely on any translated gene product, only increased readthrough transcription should be detected by the reporter system. When readthrough of the ADH2 terminator sequence in pGTP or pGTM occurs, it is directed into an ARS (autonomous replicating sequence). Consequently, ARS activity is impaired, resulting in the loss of the plasmid and the plasmid marker, SUP11. SUP11 is a tRNA suppressor that suppresses the nonsense mutation ade2-101. Failure to suppress the mutant ade2 allele results in accumulation of a red pigment. Thus, a transcription termination defect leads to increased levels of transcription into the ARS and, consequently, increased numbers of red (or sectored) colonies. The pGTP construct terminates transcription in a wild-type strain; however, trans-acting mutations that affect the transcription termination reaction lead to readthrough into the ARS, resulting in plasmid destabilization. The plasmid pGTM that will consistently fail to terminate transcription because of a cis-acting sequence mutation serves as a control. Of the four mutants examined with the plasmid loss assay, both phenotypes consistent with a defect in transcription termination (2-1-1) and inconsistent with a termination defect (4-16-1) were observed.




View larger version (54K):
In this window
In a new window
Download PPT slide
 
Figure 2. Plasmid loss analysis. (A) Plasmid loss reporter constructs. When the plasmid constructs (pGTP and pGTM), which contain both sup11 and URA3 as selectable markers, are transformed into wild-type and mutant cells, readthrough can be evaluated on the basis of rates of plasmid loss. The ADH2 3'-end sequence in either the plus (right arrow) or minus (left arrow) orientation was placed between a galactose-inducible promoter and the H4ARS. Only in a transcription termination competent strain will the ADH2 terminator prevent readthrough into the H4ARS sequence and maintain the plasmid, allowing production of sup11 and formation of white colonies. (B) Graphic representation of plasmid loss rate. YPH499, 2-1-1, and 4-16-1 cells transformed with pGTP or pGTM were grown in rich media containing either dextrose (glucose) or galactose. At various time intervals, samples were plated to YPD. Once colonies formed, red colonies vs. non-red (white and sectored) colonies were scored, and the percent plasmid maintenance was calculated. The data shown represent the average of at least three independent samples.

In vitro transcription termination:
We focused on the 2-1-1 strain because it displayed defects in growth at the permissive temperature that were exacerbated at higher temperatures, ß-galactosidase production, and RNA expression. Additionally, this strain exhibited equal rates of plasmid loss regardless of the presence of a functional terminator in the plasmid loss assay (Figure 2B). To confirm the 3'-end formation defect, we extended this analysis to include a more direct assay that examines transcription termination in vitro by nuclear extracts prepared from 2-1-1. The plasmid pBEVY (MILLER et al. 1998 Down) served as an ideal template for the in vitro transcription reaction, in that it allows evaluation of transcripts produced from two different promoters (GPD and ADH1) directed into two different 3'-end sequences (ADH1 and ADH2, respectively; Figure 3A). Extracts from strain 2-1-1 showed two significant differences from wild extracts. First, the level of specific terminated transcription product decreased as the temperature increased (compare lanes 1–4 to 5–8 in Figure 3B). Second, a high molecular weight, heterogeneous "smear" accumulated as the temperature increased. This is shown most clearly in Figure 3B, lanes 9 (wild type) and 10 (mutant), with a longer exposure of the 37° samples shown in lanes 4 and 8. The presence of the longer transcripts, coupled with the strong evidence of transcriptional readthrough by both plasmid loss analysis and Northern analysis, indicates these observations are consistent with a defect in transcription termination. Similar results are observed using a transcription template with a different promoter and a different 3'-end sequence as shown in Figure 3C. Taken together these results demonstrate that the transcription termination defect of the 2-1-1 strain is not dependent on the context of the transcription reaction. Additionally, extracts prepared from strain 2-1-1 were examined kinetically to determine if the extracts were completely deficient in processing or if slower transcription kinetics were evident. When transcription was examined in the mutant extracts at various time points during a 2-hr period, defects in producing the wild-type pattern of transcription products were evident at all time points examined (data not shown).




View larger version (37K):
In this window
In a new window
Download PPT slide
 
Figure 3. In vitro transcription termination of strain 2-1-1. (A) Templates used for in vitro transcription. Termination of transcripts is driven by the ADH1 promoter within the ADH2 3'-end at both permissive and nonpermissive temperatures, as well as within the ADH1 3'-end, driven by the GPD promoter. (B) Results of in vitro transcription using the ADH2 3'-end containing template or (C) the ADH1 3'-end containing template. In vitro transcription was completed at four temperatures (16°, 24°, 30°, and 37°). Following electrophoresis in a 1.5%-agarose/formaldehyde gel, transcripts were detected with an antisense probe specific for the ADH2 3'-end or an ADH1 3'-end-specific probe. The extra panel in B displays a longer exposure of the 37° reactions. Arrows point to the expected terminated transcripts.

Genetic analysis of 2-1-1:
On the basis of the evidence of a termination defect in strain 2-1-1, genetic studies were initiated. After 2-1-1 was mated to the wild-type strain, YPH500, the resulting strain was able to grow at 37°, thus demonstrating the 2-1-1 mutation is recessive. Unfortunately genetic analysis of strain 2-1-1 has been hampered by poor sporulation efficiency of the diploid and low spore viability. Consequently, random spore analysis was completed to establish linkage between the temperature-sensitive growth phenotype and overproduction of ß-galactosidase from the pL101 reporter. Temperature sensitivity was present in approximately half of the >100 segregants examined, indicating 2:2 segregation of this phenotype. In addition, ß-galactosidase production from pL101 at 30° was evident in all segregants that were temperature sensitive but none of these segregants were wild type for growth at 37°. Thus the data indicate that the termination defect and the growth defect are closely linked and that these phenotypes resulted from mutation in a single gene.

Cloning of the gene responsible for the mutant phenotypes of 2-1-1:
A centromere-based library was used to identify the wild-type gene corresponding to the 2-1-1 mutation. We recovered 13 transformants that grew at the nonpermissive temperature in a screen of ~20 genome-equivalents of DNA. Restriction analysis and sequencing of the complementing plasmids from these strains demonstrated that 12 were overlapping members of one of three identical plasmid clones (p366/57, p366/76, and p366/711; Figure 4). These plasmids restored the wild-type growth phenotype (Figure 5A), wild-type levels of ß-galactosidase phenotype (Figure 5B), and a wild-type RNA phenotype (Figure 5, C). Thus, a single segment of DNA complemented all three phenotypes, supporting our genetic evidence that the phenotypes resulted from mutation of a single gene. A search of the yeast database (BLAST) revealed that all three complementing fragments were from a region of chromosome II containing four potential genes: GRS1, a putative glycyl-tRNA synthetase; MRPL36, a mitochondrial ribosomal protein; TFC1, the 95-kD subunit of TFIIIC, a RNA polymerase III transcription factor; and YBR124w, an open reading frame of unidentified function (Figure 4).



View larger version (18K):
In this window
In a new window
Download PPT slide
 
Figure 4. A map of the genomic inserts used to determine which gene complements the temperature-sensitive phenotype of mutant 2-1-1. The 7-kb insert that has complementing activity is shown in detail. The three overlapping fragments isolated in our original cloning (57, 76, 711), as well as the inserts derived from chromosome II used in clones to verify the complementing activity of GRS1 (76{Delta}GRS1, 57{Delta}TFC1, TFC1, GRS1, MRPL36, and YBR124W) are shown. The ability of the inserts to complement the 37° growth defect in the plasmid host p366 or YCplac111 is shown.





View larger version (99K):
In this window
In a new window
Download PPT slide
 
Figure 5. Complementation of defects in strain 2-1-1 by complementing clones. (A) Complementation of growth defect. An approximately equal number of cells were streaked onto minimal media and incubated at the indicated temperatures. (B) Complementation of ß-galactosidase activity. Cells containing the pL101 reporter plasmid were grown in complete minimal galactose media without uracil and leucine at the permissive temperature (24°). During early log the cultures were shifted to various temperatures (30° and 37°) and grown for several additional generations (3–4 generations) until the OD600 was 1.0–1.5. Cells were collected by centrifugation, and equal volumes of cells dispensed onto an X-Gal containing indicator plate. (C) RNA defect. Northern analysis of 5 µg of total RNA prepared from cells shifted from permissive to nonpermissive temperature, as described in B. Transcripts were detected using radiolabeled antisense probes to ADH2 3'-end and URA3 (as a loading control). Lane a contains 2-1-1 plus pL101 and p366; lane b contains 2-1-1 plus pL101 and p366/57; lane c contains 499 plus pL101 and p366. The graph shows results of quantitation obtained by Phosphoimager analysis.

The GRS1 gene complements the temperature sensitivity and transcription termination defects of strain 2-1-1:
The four genes contained in the overlapping fragment were individually cloned into a yeast centromeric vector, creating YCp111/TFC1, YCp111/MRPL36, YCp111/YBR124w, and YCp111/GRS1 (Figure 4). Of these, YCp111/GRS1 was able to support growth at 37° (Figure 4 and Figure 6A), whereas the other three plasmids could not do so. In a complementing approach, we constructed deletions of single genes from the original complementing clones yielding the plasmids p366/76{Delta}GRS1 and p366/57{Delta}TFC1 (Figure 4). Deletion of the GRS1 gene from the genomic library fragment in p366 resulted in a plasmid that could not support growth of the 2-1-1 strain at 37°; deletion of the TFC1 gene, by contrast, did not affect the complementing activity of p366/57 (Figure 6A). Thus, upon subcloning of the original plasmids, as well as deletion analysis, we determined that the GRS1 gene, which codes for the probable glycyl-tRNA synthetase (FELDMANN et al. 1994 Down), could complement the growth defects of 2-1-1 (Figure 6A). The designation of Grs1p as a synthetase is based on significant homology to other glycl-tRNA synthetases, notably the human glycyl-tRNA synthetase with 60% identity to Grs1p (FREIST et al. 1996 Down). As the only potential nonmitochondrial glycyl-tRNA synthetase in the yeast genome database, Grs1p is very likely to function in this role; however, to date, a direct examination of synthetase activity has not been reported.



View larger version (43K):
In this window
In a new window
Download PPT slide
 
Figure 6. Identification of GRS1 as complementing clone. (A) Complementation of growth defect by GRS1. Transformed cells were grown at 37°. A, 2-1-1 plus p366/76; B, YPH499 plus p366; C and D, YCp111/GRS1; E, Ycplac111; F, p366/57{Delta}TFC1; G, p366/76{Delta}GRS1; and H, p366. (B) Growth phenotype of YCM101. Growth at 37° and 30° on rich media is shown. A, W303; B, YCM101 (grs1-1 integrated and looped out); C, YCM102 (grs1-1 integrated into GRS1 locus of W303 but not looped out).

The grs1-1 allele confers the temperature-sensitive growth defect associated with 2-1-1:
Two approaches were used to demonstrate that GRS1 is responsible for the mutant phenotypes observed in strain 2-1-1. First, we cloned the GRS1 gene from genomic DNA from wild-type and mutant strains into a centromeric plasmid. Eight clones from independent PCR reactions were obtained. The ability of the plasmid versions of GRS1 to complement the temperature-sensitive phenotype of strain 2-1-1 was determined and the results showed that the GRS1-containing clones derived from the wild-type strain were able to complement the temperature sensitivity, whereas the eight clones derived from the mutant strain were unable to do so (data not shown). This demonstrates that the 2-1-1 strain contains a mutant allele of the GRS1 locus, grs1-1.

Second, we asked whether the mutant phenotype of the 2-1-1 strain could be conferred by the grs1-1 allele that was recovered. We integrated the grs1-1 allele from 2-1-1 into a wild-type strain (W303a) at the GRS1 locus, creating YCM102, and selected for recombination events that deleted the wild-type URA3 gene located between the two alleles. The strains harboring the grs1-1 allele (YCM101) were identified by screening for temperature sensitivity at 37° (Figure 6B). To further confirm that grs1-1 is the mutant allele, YCM101 was mated to W303{alpha}, diploids were selected, and tetrad dissection was completed. The resulting segregants were transformed with the ß-galactosidase reporter plasmid, pL101, and examined at both permissive and nonpermissive temperatures. In all eight segregants examined, the spore products that were temperature sensitive on YPD at 37° also expressed increased levels of ß-galactosidase at 30°, and the spore products that grew at the nonpermissive temperature did not express increased ß-galactosidase. Given that previous random spore analysis demonstrated linkage between the temperature sensitivity and the RNA defect, this firmly establishes grs1-1 as the mutation in 2-1-1.

GRS1 is an essential gene:
We also created a heterozygote containing a grs1 null allele by inserting the kanamycin resistance gene into the GRS1 locus of a wild-type diploid (W303a/{alpha}). Upon sporulation and dissection of this diploid, we determined that GRS1 is an essential gene in that, of the 20 viable spore products, only kanamycin-sensitive strains (GRS1 gene present) were recovered. No spore product was recovered that was kanamycin resistant (GRS1 gene knocked out).

Identification of the grs1-1 mutation:
Finally, sequence analysis of the grs1-1 mutation revealed that nucleotides 1656 and 1657 were both C to T transitions that result in a single amino acid change of proline at position 552 to a phenylalanine (P552F). Two independently derived clones derived from the mutant strain (2-1-1) contained this mutant allele, whereas a clone derived from the wild-type strain (YPH499) did not harbor the transition mutation.

Examination of polyadenylation and cleavage:
To determine if defects in 3' RNA processing are evident in the grs1-1 mutant strain, whole cell extracts were prepared and in vitro cleavage and polyadenylation examined. A radiolabeled CYC1 3'-end substrate was synthesized in vitro and incubated in the presence of yeast extracts made from wild-type or 2-1-1 cells. As the grs1-1 allele is temperature sensitive, extracts were prepared from cells grown at 24°, but reactions were performed with extracts heat-treated at 37° for 5 min (Figure 7, lanes 5–8) or non-heat-treated extracts (Figure 7, lanes 1–4). In addition, a set of reactions was performed with dATP substituting for ATP to demonstrate accumulation of the upstream cleavage product (Figure 7, lanes 9–12). These results indicate that the primary defect in strain 2-1-1 and YCM101 does not affect polyadenylation or cleavage.



View larger version (58K):
In this window
In a new window
Download PPT slide
 
Figure 7. Polyadenylation and cleavage. In vitro reactions using extracts from the wild-type strain W303 (lanes 2, 6, and 10), strain 2-1-1 (lanes 3, 7, and 11), and YCM101 (lanes 4, 8, and 12) were compared to reactions with no added extract (lanes 1, 5, and 9). Heat-treated (37°) extracts were used for the reactions in lanes 5–8, and dATP was included in the reactions in lanes 9–12. A radiolabeled pre-mRNA from the 3'-end of the CYC1 gene was used as the processing substrate.

Transcription run-on:
To assess the localization of active polymerases to the regions downstream of normal transcription termination sites in the mutant strain YCM101, transcriptional run-on experiments were completed. We anticipated polymerases would localize to regions downstream from the normal transcription termination site. Data from a representative result from the transcription run-on experiment are shown in Figure 8B, and a graphic representation is shown in Figure 8C. Using the pGCYC plasmid as a template for the transcription run-on reaction (Figure 8A), we observed wild-type transcriptional patterns in the mutant strain at the permissive temperature (30°; Figure 8C, compare YCM101 at 30° to W303 at 30°). However, mutant cells shifted to the nonpermissive temperature (37°) demonstrated high polymerase density downstream from the polyadenylation site (Figure 8B). This pattern resembles the polymerase density observed in cells harboring a transcription template with a defective transcription termination site (pGcyc1-512; Figure 8C, compare cyc1-512 at 30° to CYC1 37°). Thus, increased levels of polymerase density were found in the regions downstream of the normal transcriptional termination site in the mutant strain YCM101, providing additional evidence of a defect in transcription termination in strains harboring the grs1-1 allele.



View larger version (66K):
In this window
In a new window
Download PPT slide
 
Figure 8. Transcription run-on analysis of YCM101 vs. wild type (W303). (A) Plasmid template used for TRO. (B) Representative results. Shown is a typical result obtained in TRO analysis of YCM101 transformed with pGCYC vs. W303 transformed with pGCYC shifted to 37° for one generation (2 hr) in galactose-containing media. Total cellular RNA was hybridized to a slot blot containing M13 probes specific for the regions of the CYC1 construct shown in Figure 8A. (C) Graphic representation of the results of TRO analysis. The graph represents data from at least two independent experimental samples. The dark bars are from strain YCM101 and the light bars are from W303.


*  DISCUSSION
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

RNA defects associated with the grs1-1 mutation:
The observation that an enzyme traditionally associated with the aminoacylation of tRNA affects 3'-end formation is unexpected. Because of the role of tRNA synthetases in translation, an indirect role for Grs1p may be predicted in that translation of a factor essential for 3'-end formation might be adversely affected in the absence of a pool of correctly aminoacylated tRNAgly. Yet, we clearly observe defects in RNA processing and metabolism consistent with a defect in 3'-end formation using multiple assays. First, Northern analysis demonstrates a defect in transcription termination. We observe a decrease in the level of terminated transcripts as the temperature is increased in our mutant strains (2-1-1 and YCM101) compared to the wild-type strain. Examination of the expression of a control gene (URA3) indicates a correlated general decrease in transcription is not observed. Second, the plasmid loss assay demonstrates the mutant strain (2-1-1) produces increased levels of readthrough transcripts, relative to wild type. Third, in vitro analysis of the terminated RNA products shows a clear defect in accumulation of terminated products. Fourth, polyadenylation and cleavage are normal in the mutant strain. Fifth, transcription run-on results demonstrate increased polymerase density in regions downstream from a normal transcription termination site. The observed phenotypes are consistent with a general defect that affects the transcription termination reaction. A failure to demonstrate a role for GRS1 in polyadenylation is not surprising in that the polyadenylation reaction has been functionally reconstituted, and GRS1 is not a required component of the reaction (KELLER and MINVIELLE-SEBASTIA 1997 Down). Thus, these results represent the first example of a transcription termination factor in S. cerevisiae that affects transcription termination independent of 3'-end processing of mRNA.

Roles of tRNA synthetases independent from aminoacylation:
Although tRNA synthetases are traditionally thought to be responsible for charging tRNA, several lines of evidence, including what is presented in this article, demonstrate that tRNA synthetases can be multi-functional proteins. Notable is the observation that tRNA synthetases are involved in a variety of cellular functions, unlinked to their roles in protein synthesis (FIRST 1998 Down). For example, the tyrosyl-tRNA synthetase binds a region of the group I intron catalytic core, which resembles a tRNA structure (CAPRARA et al. 1996 Down) and is thought to stabilize the catalytically active intron structure, an activity generally reserved for RNA molecules (MOHR et al. 1994 Down). In addition, a role for tRNA synthetases in splicing of group II introns is postulated (LAMBOWITZ and PERLMAN 1990 Down). Another paradigm is found in bacteria where tRNA synthetases have been linked to transcription termination. Prokaryotic tRNA synthetases are able to regulate termination of their own primary transcripts (PLATT 1998 Down; YANOFSKY et al. 1996 Down). Third, an RNA-binding capacity has been identified in mammalian cells, demonstrating that human glutaminyl-tRNA synthetase binds to a secondary structure present in the 3'-end of its own primary transcript (SCHRAY and KNIPPERS 1991 Down). These observations on the roles of tRNA synthetases raise the strong possibility that the mutant phenotypes observed in our transcription termination screen are the consequence of a specific role for Grs1p in mRNA 3'-end formation in S. cerevisiae. Recent findings (LUND et al. 1998) have shown that tRNA synthetases are capable of aminoacylating tRNA in the nucleus, the site of transcription termination. These observations allow us to speculate that GRS1 is present in the nucleus of S. cerevisiae as part of the tRNA proofreading system, as well as 3'-end formation of mRNA.

Identification of tRNA-like structures in the 3'-ends of yeast genes:
As part of the specificity of the aminoacylation reaction, synthetases generally recognize the anticodon region, the acceptor arm, and additional nucleotides within the cognate tRNA. The exact mechanisms used by synthetases to bind to tRNA vary among the different synthetases and no single region of the tRNA or single domain of the synthetases is exclusively responsible for this RNA:protein interaction (FREIST et al. 1996 Down). Clearly, the overall structure of tRNA is well conserved (HINNESBUSCH and LIEBMAN 1991; MANS et al. 1991 Down; HOPPER and MARTIN 1992 Down; NAMEKI et al. 1997 Down; SHIBA et al. 1997 Down; SAKS et al. 1998 Down). Thus, we considered whether yeast mRNAs might contain sequences that would allow tRNA synthetase recognition.

An examination of the 3'-ends of several yeast mRNAs revealed the presence of a sequence that appears conserved in the 3'-end of several RNA polymerase II transcripts. The semiconserved sequence (GUUCGANYC) corresponds to the T{psi}C loop of tRNA, a critical structural feature of tRNAs (Figure 9A). Thus, the tRNA-like sequence element could potentially play a role in mediating the Grs1p interaction with 3'-ends of yeast genes transcribed by RNA polymerase II and transcription termination.



View larger version (23K):
In this window
In a new window
Download PPT slide
 
Figure 9. Hypothetical tRNA-like structures. (A) Conservation of elements in 3'-ends. The alignment of the 3'-ends of ADH2, GAL7, and CYC1, as compared to tRNAgly and a model tRNA structure is shown. Bold elements emphasize the conserved nucleotides, and the—represents insertions of nucleotides from 4 to 35 nucleotides in length. (B) Diagrammatic representation of the hypothetical tRNA-like structures. The underlined nucleotides correspond to the potential anticodon, the shadowed nucleotides to the highly conserved elements of the potential T{psi}C loop, and the bold nucleotides to the highly conserved dinucleotide sequence in the potential D-loop. Note that the site of polyadenylation is found in the acceptor arm for both the ADH2 3'-end and the GAL7 3'-end. Shown are tRNAgly, the ADH2 3'-end, the GAL7 3'-end, and the CYC1 3'-end.

Are there tRNA-like structures found at the 3'-ends of mRNA? A structure is traditionally defined as tRNA-like "on account of its ability to react efficiently with one or more tRNA-specific enzymes" (MANS et al. 1991 Down). The ability to form the classic cloverleaf conformation is not a necessary prerequisite for being classified tRNA-like. As shown in Figure 9A and Figure B, the 3'-ends of GAL7, CYC1, and ADH2, three classically investigated RNA polymerase II transcriptional terminators, contain a potential tRNA-like structure that is defined by the following: an element that resembles the T{psi}C loop; a GG sequence in a region that is a potential D-loop; an anticodon that would not charge any amino acid to the RNA (UUA); and, in two of three examples, an acceptor arm that contains the polyadenylation site (RUSSO and SHERMAN 1989 Down; HYMAN et al. 1991 Down). The stems in the structures as drawn are not predicted to be of comparable stability as those found in a typical tRNA; however, the tertiary structure of some previously described tRNA-like molecules stabilizes comparable structures in other RNA molecules (MANS et al. 1991 Down). In fact, tRNA tertiary structure is reported to be stabilized by interactions between the GG dinucleotide present in the D-loop and bases within the T{psi}C loop (reviewed in SCHIMMEL and ALEXANDER 1998 Down). Additionally, site-directed mutagenesis of a conserved nucleotide from the T{psi}C-like element of the ADH2 3'-end did increase the level of readthrough in our reporter construct (data not shown).

The presence of a potential tRNA-like structure allows one to envision a role for tRNA processing components, such as tRNA synthetases, in the mRNA 3'-end formation reaction. Furthermore, the grs1-1 mutation may affect some aspect of the synthetase involved in charging tRNA may be a mutation that is exclusively involved in 3'-end formation, demonstrating a role for the protein distinct from its role in protein synthesis. As noted, tRNA synthetases recognize tRNA as a part of the aminoacylation reaction; yet, some have been observed to bind to or interact with other RNAs, including rRNA and mRNA (LABOUESSE 1990 Down; SCHRAY and KNIPPERS 1991 Down; MOHR et al. 1994 Down; CAPRARA et al. 1996 Down).

DNA sequencing of the grs1-1 gene predicts a single amino acid change from proline to phenylalanine at position 552. Importantly, the crystal structure of the glycyl-tRNA synthetase from Thermus thermophilus has been solved and the C-terminal domain that contains the mutation in Grs1p is thought to constitute the domain that recognizes and binds to the tRNA at the anticodon loop (LOGAN et al. 1995 Down). A P to F mutation, such as the one found in grs1-1, is likely to adversely affect this domain and suggests that RNA recognition may be modified in the mutant protein. Importantly the yeast enzyme is conserved in this domain with the T. thermophilus sequence (data not shown). Thus, an inability of the glycl-tRNA synthetase mutant to recognize a structure in the mRNA 3'-end may account for the decreased levels of termination observed in a grs1-1 mutant.

Other 3'-end formation effectors with roles in tRNA metabolism:
Grs1p is not the only trans-acting factor implicated in 3'-end formation with roles in tRNA metabolism. PTA1 has been described both as an effector of pre-tRNA processing (O'CONNOR and PEEBLES 1992 Down) and as component of both PFI and CFII, factors important for the polyadenylation (PREKER et al. 1997 Down) and cleavage of mRNA (C. MOORE, personal communication). Additionally, an examination of an RNA pseudoknot in the 3'-untranslated region of tobacco mosaic virus indicates the sequence forms a structure similar to a tRNA. This structure is recognized by tRNA synthetases and can serve as the 3'-terminus of mRNA to functionally substitute for a poly(A) tail (GALLIE and WALBOT 1990 Down). Also, a defect in RET1, the gene for the second largest subunit of RNA polymerase III, has been demonstrated to suppress a lethal mutation of poly(A)-polymerase, and an association of RNA polymerase III with the 3'-end formation components has been suggested (BRIGGS and BUTLER 1996 Down). Finally, RNAs that can function as both tRNA and mRNA, termed tmRNA, have been identified in bacterial systems (MUTO et al. 1998 Down). These observations suggest that RNA metabolism, recognition, and function is not as nonoverlapping and polymerase-specific as traditionally envisioned.


*  FOOTNOTES

1 Present address: Department of Biology, Troy State University, Troy, AL 36081. Back


*  ACKNOWLEDGMENTS

We thank Dr. M. Clancy, S. Chen, S. Gross, K. Johanson, R. Boumil, D. Nemergut, and M. Magrath for their expert technical assistance and Drs. C. Moore, N. Proudfoot, and C. Miller for providing molecular reagents used for portions of the work described in this manuscript. We also acknowledge S. Gross, T. Jackson, and Drs. R. Baricos, M. Clancy, D. Dawson, E. First, A. Lustig, C. Miller, and C. Moore, as well as the members of the labs of Drs. Hyman and Lustig for valuable discussions. This research was supported by the National Science Foundation grant MCB9604295 to L. E. Hyman. C. Magrath was funded by the Louisiana Education Quality Support Fund Fellowship.

Manuscript received September 1, 1998; Accepted for publication February 9, 1999.


*  LITERATURE CITED
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

ALTSCHUL, S. F., W. GISH, W. MILLER, E. W. MYERS, and D. J. LIPMAN, 1990  Basic local alignment search tool. J. Mol. Biol. 215:403-410[Medline].

AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN et al. 1994 Current Protocols in Molecular Biology. John Wiley & Sons, New York.

BIRSE, C. E., L. MINVIELLE-SEBASTIA, B. A. LEE, W. KELLER, and N. J. PROUDFOOT, 1998  Coupling termination of transcription to messenger RNA maturation in yeast. Science 280:298-301[Abstract/Free Full Text].

BRIGGS, M. W. and J. S. BUTLER, 1996  RNA polymerase III defects suppress a conditional lethal poly(A) polymerase mutation in Saccharomyces cerevisiae.. Genetics 143:1149-1161[Abstract].

BRIGGS, M. W., K. T. BURKARD, and S. J. BUTLER, 1998  Rrp6p, the yeast homologue of the human PM-Scl 100 kDA autoantigen, is essential for efficient 5.8 S 3'-end formation. J. Biol. Chem. 273:13255-13263[Abstract/Free Full Text].

BUTLER, J. S. and T. PLATT, 1988  RNA processing generates the mature 3' ends of yeast CYC1 mRNA in vitro. Science 242:1270-1274[Abstract/Free Full Text].

CAPRARA, M. G., V. LEHNERT, A. M. LAMBOWITZ, and E. WESTHOF, 1996  A tyrosyl-tRNA synthetase recognizes a conserved tRNA-like structural motif in the group I intron catalytic core. Cell 87:1135-1145[Medline].

CHEN, J. and C. L. MOORE, 1992  Separation of factors required for cleavage and polyadenylation of yeast pre-mRNA. Mol. Cell. Biol. 12:3470-3481[Abstract/Free Full Text].

CHEN, S., R. REGER, C. MILLER, and L. E. HYMAN, 1996  Transcriptional terminators are associated with origins of replication in yeast. Nucleic Acids Res. 15:2885-2893.

CHERRY, J. M., C. BALL, S. WENG, G. JUVIK, and R. SCHMIDT et al., 1997  Genetic and physical maps of Saccharomyces cerevisiae.. Nature 387:67-73[Medline].

COLGAN, D. F. and J. L. MANLEY, 1997  Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11:2734-2766.

EGGERMONT, J. and N. PROUDFOOT, 1993  Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters. EMBO J. 12:2539-2548[Medline].

FELDMANN, H., G. MANNHAUPT, C. SCHWARZLOSE and J. VETTER, 1994 A probable gene of GlyRS from Saccharomyces cerevisiae. EMBL Protein Sequence Data Base, accession no. Z35990.

FIRMENICH, A. and K. REDDING, 1993  An efficient procedure for multiple transformations of yeast in parallel. Biotechniques 14:712-718[Medline].

FIRST, E., 1998 Catalysis of tRNA aminoacylation by class I and class II aminoacyl-tRNA synthetases, pp. 573–607 in Comprehensive Biological Catalysis. Academic Press, San Diego.

FREIST, W., D. T. LOGAN, and D. H. GAUSS, 1996  Glycyl-tRNA synthetase. Biol. Chem. Hoppe-Seyler 377:343-356[Medline].

GALLIE, D. R. and V. WALBOT, 1990  RNA pseudoknot domain of tobacco mosaic virus can functionally substitute for a poly(A) tail in plant and animal cells. Genes Dev. 4:1149-1157[Abstract/Free Full Text].

GIETZ, D., A. ST. JEAN, R. WOODS, and R. H. SCHIESTL, 1992  Improved method for high-efficiency transformation of intact yeast cells. Nucleic Acids Res. 20:1425[Free Full Text].

GREGER, I. H., F. DEMARCHI, M. GIACCA, and N. J. PROUDFOOT, 1998  Transcriptional interference perturbs the binding of SP1 to the HIV-1 promoter. Nucleic Acids Res. 26:1294-1300[Abstract/Free Full Text].

GULDENER, U., S. HECK, T. FIEDLER, J. BEINHAUER, and J. HEGEMANN, 1996  A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res. 24:2519-2524[Abstract/Free Full Text].

GUTHRIE, C., and G. R. FINK, 1991 Guide to Yeast Genetics and Molecular Biology. Academic Press, San Diego.

HANI, J., B. SCHELBERT, A. BERNHARDT, H. DONDEY, and G. FISCHER et al., 1999  Mutations in a peptidyl prolyl-cis/trans-isomerase gene lead to a defect in 3'-end formation of a pre-mRNA in Saccharomyces cerevisiae.. J. Biol. Chem. 274:108-116[Abstract/Free Full Text].

HIETER, P., C. MANN, M. SNYDER, and R. DAVIS, 1985  Mitotic stability of yeast chromosomes: a colony color assay that measures nondisjunction and chromosome loss. Cell 40:381-392[Medline].

HINNEBUSCH, A. G., and S. W. LIEBMAN, 1991 Protein synthesis and translational control in Saccharomyces cerevisiae, pp. 627–735 in The Molecular and Cellular Biology of the Yeast Saccharomyces cerevisiae: Genome Dynamics, Protein Synthesis, and Energetics, edited by J. R. BROACH, J. R. PRINGLE and E. W. JONES. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

HOPPER, A., and N. MARTIN, 1992 Processing of yeast cytoplasmic and mitochondrial precursor tRNAs, pp. 99–141 in The Molecular and Cellular Biology of the Yeast Saccharomyces cerevisiae: Gene Expression, edited by E. W. JONES, J. R. PRINGLE and J. R. BROACH. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

HYMAN, L. E. and C. L. MOORE, 1993  Termination and pausing of RNA polymerase II downstream of yeast polyadenylation sites. Mol. Cell. Biol. 13:5159-5167[Abstract/Free Full Text].

HYMAN, L. E., S. H. SEILER, J. WHORISKEY, and C. L. MOORE, 1991  Point mutations upstream of the yeast ADH2 poly(A) site significantly reduce the efficiency of 3'-end formation. Mol. Cell. Biol. 11:2004-2012[Abstract/Free Full Text].

JOHNSTON, M. and R. W. DAVIS, 1984  Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae.. Mol. Cell. Biol. 4:1440-1448[Abstract/Free Full Text].

KELLER, W. and L. MINVIELLE-SEBASTIA, 1997  A comparison of mammalian and yeast pre-mRNA 3'-end processing. Curr. Opin. Cell Biol. 9:329-336[Medline].

KOSHLAND, D., J. KENT, and L. HARTWELL, 1985  Genetic analysis of mitotic transmission of minichromosomes. Cell 40:393-403[Medline].

LABOUESSE, M., 1990  The yeast mitochondrial leucyl-RNA synthethase is a splicing factor for the excision of several group I introns. Mol. Gen. Genet. 224:209-221[Medline].

LAMBOWITZ, A. M. and P. S. PERLMAN, 1990  Involvement of aminoacyl-tRNA synthethases and other proteins in group I and group II intron splicing. Trends Biochem. Sci. 15:440-444[Medline].

LOGAN, D. T., M. H. MAZAURIC, D. KERN, and D. MORAS, 1995  Crystal structure of glycyl-RNA synthetase from Thermus thermophilus.. EMBO J. 14:4156-4167[Medline].

LUE, N. F. and R. D. KORNBERG, 1987  Accurate initiation at RNA polymerase II promoters in extracts from Saccharomyces cerevisiae.. Proc. Natl. Acad. Sci. USA 84:8839-8843[Abstract/Free Full Text].

LUE, N. F., P. M. FLANAGAN, R. J. KELLEHER, III, A. EDWARDS, and R. D. KORNBERG, 1991  RNA polymerase II transcription in vitro.. Methods Enzymol. 194:545-549[Medline].

LUND, E. and J. DAHLBERG, 1998  Proofreading and aminoacylation of tRNAs before export from the nucleus. Science 282:2082-2085[Abstract/Free Full Text].

MANS, R. M. W., C. W. A. PLEIJ, and L. BOSCH, 1991  tRNA-like structures. Eur. J. Biochem. 201:303-324[Medline].

MCCRACKEN, S. M., N. FONG, K. YANKULOV, S. BALLANTYNE, and G. PAN et al., 1997  The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385:357-361[Medline].

MILLER, C., M. A. MARTINAT, and L. E. HYMAN, 1998  Assessment of aryl hydrocarbon receptor complex interaction using pBEVY plasmids: a family of yeast expression vectors with bidirectional promoters. Nucleic Acids Res. 24:3577-3583.

MOHR, G., M. G. CAPRARA, Q. GUO, and A. M. LAMBOWITZ, 1994  A tyrosyl-tRNA synthetase can function similarly to an RNA structure in the Tetrahymena ribozyme. Nature 370:147-150[Medline].

MUTO, A., C. USHIDA, and H. HIMENO, 1998  A bacterial RNA that functions as both a tRNA and an mRNA. Trends Biochem. Sci. 23:25-29[Medline].

NAMEKI, N., K. TAMURA, H. ASAHARA, and T. HASEGAWA, 1997  Recognition of tRNA(Gly) by three widely diverged glycyl-tRNA synthetases. J. Mol. Biol. 268:640-647[Medline].

O'CONNOR, J. P. and C. L. PEEBLES, 1992  PTA1, an essential gene of Saccharomyces cerevisiae affecting pre-tRNA processing. Mol. Cell. Biol. 12:3843-3856[Abstract/Free Full Text].

PLATT, T., 1998 RNA structure in transcription elongation, termination, and antitermination, pp. 541–574 in RNA Structure and Function, edited by R. SIMONS and M. GRUNBERG-MANAGO. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

PREKER, P. J., M. OHNACKER, L. MINVIELLE-SEBASTIA, and W. KELLER, 1997  A multisubunit 3'-end processing factor from yeast containing poly(A) polymerase and homologues of the subunits of mammalian cleavage and polyadenylation specificity factor. EMBO J. 16:4727-4737[Medline].

PROUDFOOT, N. J., 1986  Transcriptional interference and termination between duplicated {alpha}-globin gene constructs suggests a novel mechanism for gene regulation. Nature 322:562-565[Medline].

ROSE, M. D., P. NOVICK, J. H. THOMAS, D. BOTSTEIN, and G. R. FINK, 1987  A Saccharomyces cerevisiae genomic bank based on centromere-containing shuttle vector. Gene 60:237-243[Medline].

RUSSNAK, R., K. W. NEHRKE, and T. PLATT, 1995  REF2 encodes an RNA binding protein directly involved in yeast mRNA 3'-end formation. Mol. Cell. Biol. 15:1689-1697[Abstract].

RUSSO, P., 1995  Saccharomyces cerevisiae mRNA 3'-end forming signals are also involved in transcription termination. Yeast 11:447-453[Medline].

RUSSO, P. and F. SHERMAN, 1989  Transcription terminates near the poly(A) site in the CYC1 gene of the yeast Saccharomyces cerevisiae.. Proc. Natl. Acad. Sci. USA 86:8348-8352[Abstract/Free Full Text].

SAKS, M., J. SAMPSON, and J. ABELSON, 1998  Evolution of a transfer RNA gene through a point mutation in the anticodon. Science 279:1665-1670[Abstract/Free Full Text].

SCHIMMEL, P. and R. ALEXANDER, 1998  All you need is RNA. Science 281:658-659[Free Full Text].

SCHRAY, B. and R. KNIPPERS, 1991  Binding of human glutaminyl-tRNA synthetase to a specific site of its mRNA. Nucleic Acids Res. 19:5307-5312[Abstract/Free Full Text].

SHERMAN, F., G. R. FINK and J. B. HICKS, 1986 Laboratory Course Manual for Methods in Yeast Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

SHIBA, K., H. MOTEGI, and P. SCHIMMEL, 1997  Maintaining genetic code through adaptations of tRNA synthetases to taxonomic domains. Trends Biochem. Sci. 22:453-457[Medline].

SNYDER, M., R. J. SAPOLSKY, and R. W. DAVIS, 1988  Transcription interferes with elements important for chromosome maintenance in Saccharomyces cerevisiae.. Mol. Cell. Biol. 8:2184-2194[Abstract/Free Full Text].

SPRINGER, C., O. VALERIUS, A. SRITTMATTER, and G. BRAUS, 1997  The adjacent yeast genes ARO4 and HIS7 carry no intergenic regions. J. Biol. Chem. 272:23618-23624.

STEINMETZ, E., 1997  Pre-mRNA processing and the CTD of RNA polymerase II: the tail that wags the dog? Cell 89:491-494[Medline].

WAHLE, E. and W. KELLER, 1996  The biochemistry of polyadenylation. Trends Biochem. Sci. 21:247-250[Medline].

WHITELAW, E. and N. PROUDFOOT, 1986  Alpha-Thalassaemia caused by a poly(A) site mutation reveals that transcriptional termination is linked to 3'-end processing in the human {alpha}-globin gene. EMBO J. 5:2915-2922[Medline].

YANOFSKY, C., K. V. KONAN, and J. P. SARSERO, 1996  Some novel transcription attenuation mechanisms used by bacteria. Biochimie 78:1017-1024[Medline].

ZARET, K. S. and F. SHERMAN, 1982  DNA sequence required for efficient transcription termination in yeast. Cell 28:563-573[Medline].




This article has been cited by other articles:


Home page
Genes Dev.Home page
E. Rosonina, S. Kaneko, and J. L. Manley
Terminating the transcript: breaking up is hard to do.
Genes & Dev., May 1, 2006; 20(9): 1050 - 1056.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Johanson, T. Hoang, M. Sheth, and L. E. Hyman
GRS1, a Yeast tRNA Synthetase with a Role in mRNA 3' End Formation
J. Biol. Chem., September 19, 2003; 278(38): 35923 - 35930.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Nedea, X. He, M. Kim, J. Pootoolal, G. Zhong, V. Canadien, T. Hughes, S. Buratowski, C. L. Moore, and J. Greenblatt
Organization and Function of APT, a Subcomplex of the Yeast Cleavage and Polyadenylation Factor Involved in the Formation of mRNA and Small Nucleolar RNA 3'-Ends
J. Biol. Chem., August 29, 2003; 278(35): 33000 - 33010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. E. Hyman, E. Kwon, S. Ghosh, J. McGee, A. M. B. Chachulska, T. Jackson, and W. H. Baricos
Binding to Elongin C Inhibits Degradation of Interacting Proteins in Yeast
J. Biol. Chem., May 3, 2002; 277(18): 15586 - 15591.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. A. Carrodeguas and D. F. Bogenhagen
Protein sequences conserved in prokaryotic aminoacyl-tRNA synthetases are important for the activity of the processivity factor of human mitochondrial DNA polymerase
Nucleic Acids Res., March 1, 2000; 28(5): 1237 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Zhao, M. Kessler, S. Helmling, J. P. O'Connor, and C. Moore
Pta1, a Component of Yeast CF II, Is Required for Both Cleavage and Poly(A) Addition of mRNA Precursor
Mol. Cell. Biol., November 1, 1999; 19(11): 7733 - 7740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Turner, M. Lovato, and P. Schimmel
One of Two Genes Encoding Glycyl-tRNA Synthetase in Saccharomyces cerevisiae Provides Mitochondrial and Cytoplasmic Functions
J. Biol. Chem., September 1, 2000; 275(36): 27681 - 27688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-M. Duchene, N. Peeters, A. Dietrich, A. Cosset, I. D. Small, and H. Wintz
Overlapping Destinations for Two Dual Targeted Glycyl-tRNA Synthetases in Arabidopsis thaliana and Phaseolus vulgaris
J. Biol. Chem., April 27, 2001; 276(18): 15275 - 15283.
[Abstract] [Full Text] [PDF]